Key result
Normothermic venous inflow occlusion enables cardiac chondrosarcoma resection, with tumor recurrence at ~309 days.
Why the study?
Use of normothermic venous inflow occlusion for intracardiac tumor resection in dogs had not been well described.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
May enable beating-heart resection of canine intracardiac tumors; leaves open need for larger series on safety and outcomes.
Use of normothermic venous inflow occlusion enabled removal of an intracardiac tumor in a 4 yr old, 27 kg, spayed female Airedale terrier with a history of appendicular osteosarcoma and recent exertional syncope. Inflow venous occlusion via a median sternotomy thoracotomy without hypothermia was used to access the mineralized mass within the right ventricular outflow tract. Duration of circulatory arrest was 70 s for this beating heart surgery. A circumscribed intracardiac chondrosarcoma tumor was marginally resected in this dog, successfully alleviating exertional syncope and restoring a normal echogenic appearance of the right heart. Asymptomatic intracardiac chondrosarcoma recurrence and pulmonary metastasis was detected at 309 days and cardiopulmonary arrest occurred 372 days following intracardiac surgery. Use of inflow occlusion is a viable technique for select intracardiac tumors in dogs with preoperative planning.
No takes yet. Share an insight, caveat, or question.
Worley et al. (2016) conducted a case report in Intracardiac tumor (right ventricular outflow tract chondrosarcoma) (n=1). Normothermic venous inflow occlusion was evaluated. Normothermic venous inflow occlusion enabled successful marginal resection of an intracardiac chondrosarcoma, with recurrence at 309 days and cardiopulmonary arrest at 372 days.
Synapse has enriched 10 related papers. Consider them for comparative context: